HOME COMPANY OUR VALUE PROJECTS NEWS EVENTS ABOUT MEDSIR CONTACT US! Events On top of generating and managing strategic clinical trials in Oncology for many of the most important drugs on the market such as osimertinib, pembrolizumab, pertuzumab, T-DM1, olaparib, niraparib, eribulin, palbociclib, fulvestrant, and radium-223, over the last few years MedSIR has organized large scientific events, bringing together a number of international key opinion leaders in Oncology and Basic Research to discuss cutting edge topics in an environment that promotes proactivity and a dynamic interchange of ideas. Not surprisingly, many ideas for future studies have stemmed from these gatherings. For example, MedSIR will launch its first trials using Immunotherapy (atezolizumab and pembrolizumab) that were developed with ideas stemming from its Immunology Workshop. Additional strategic ideas were generated from other events such as MedSIR’s European Think Tank on Breast Cancer. For more specific information of these events, we invite you to click on the links below… HELPING PATIENTS WORLDWIDE 1.181 patients SUCCESSFULLY ENROLLED FOLLOW US ON TWITTER FEED Follow @medsir2012 MedSIR @medsir2012 2 days ago Rachael Bland, BBC presenter and cancer blogger, reveals she has just 'days left to live' https://t.co/z8W6f1jMlC via @telegraphnews #Cancer View on Twitter MedSIR @medsir2012 2 days ago 😐☹️😭 https://t.co/0rSs0bnn6Z View on Twitter RadioToday UK @RadioToday Devastating news as 5 live's Rachel Bland shares that she has just days left to live https://t.co/PBsMiKgQaq https://t.co/xFfQRlSD5V INSTAGRAM FEED Follow us on Instagram FACEBOOK FEED MedSIR It is a great pleasure to welcome you to MedSIR, a private company founded by Oncology experts in 2012. Together, not only we do make up an international team with many years of high-level clinical and research experience, but also, and even more importantly, a team that is passionate about helping you, our clients, to get your best and most innovative treatments to our patients as efficiently and quickly as possible. Along the way, we strive to improve our scientific knowledge of this complex disease and the large array of available treatments, producing a win-win-win situation for your company, for our patients, and for the scientific community. This endeavor requires strong and creative minds to generate novel, out-of-the-box ideas, as well as a high-level operations team behind the scenes that brings these strategic ideas to life. At MedSIR we have the complete package that is changing the way IIS Research is being done. Bring your idea to life💡 Design & Management of Clinical Trials 📊 Medica Scientia Innovation Research (MedSIR) MedSIR15 hours ago Dicen que la ciencia arruina toda la diversión y esta semana, nuevamente se fueron en contra de uno de los pasatiempos favoritos de la gente: comer dulces. #Oncología #Cáncer #Berlines #Dulces Coman tranquilos: La verdad acerca del cáncer y los berlines . mouse.latercera.com 3 View on Facebook MedSIR2 days ago Las células transportan virus oncolíticos que son capaces de destruir células cancerígenas del tumor del paciente. https://www.20minutos.es/noticia/3430043/0/un-caballo-troya-luchar-contra-el-cancer/ #Oncología #Cáncer #Investigación Celyvir, la novedosa terapia para luchar contra el cáncer Investigadores españoles están trabajando en una novedosa terapia, registrada como 'Celyvir', que actúa como una especie de 'caballo de Troya' para... 20minutos.es 34 View on Facebook FOLLOW US ON COMPANY · Welcome · Our Vision · The MedSIR Team · From Barcelona… OUR VALUE · Scientific Board · Strategic Trial Design · Idea Submission · Commitment to Quality PROJECTS · Current Projects · Closed Projects · Publications · #medsireverywhere NEWS & EVENTS · News · Events ABOUT · FAQ · Testimonials · Contact Us! GET OUR MONTHLY NEWSLETTER! First name: Last name: Email address: Before you sign the application, you should read the basic information on data protection listed here I accept the sending of periodic commercial communications by MEDICA SCIENTIA INNOVATION RESEARCH, SL Please choose your area of interest: Healthcare/Academic Professional Pharma/Biotech Professional Other Companies Action to perform: Subscribe Unsubscribe © 2018 MedSIR | Privacy Policy | Legal Notice | Official Notice | Cookie Policy | info@medsir.org We'll assume you're ok with this, but you can opt-out if you wish.Accept